Acceptability of Mixed Stage, Mixed Tumour Group Psych-Oncology Therapy: Insights from an Exploratory Qualitative Study
This exploratory qualitative study found that mixed tumour and mixed-stage psycho-oncology groups are generally acceptable to patients, provided the focus remains on shared psychological challenges and the groups are supported by access to individual care to address stage-related sensitivities.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a person receives a cancer diagnosis, the physical battle to treat the disease is only part of the story. The news often brings a heavy wave of emotional distress, including anxiety, depression, and a sense of isolation that can make daily life feel overwhelming. For many, talking to a therapist helps, but the demand for these specialized psychological services far outstrips the number of available experts. To bridge this gap, healthcare systems are looking at group therapy, where several people meet together to share their experiences and learn coping strategies. While this approach is known to work for many conditions, a specific question remains for cancer care: is it safe and helpful to mix people with different types of cancer in the same room? Furthermore, is it wise to mix people who are in the early stages of their journey with those who are facing advanced or terminal illness? The fear is that such differences might cause more harm than good, perhaps by making someone feel misunderstood or by exposing them to frightening outcomes that increase their own anxiety.
Researchers at The University of Melbourne and Northern Health in Australia set out to answer these questions by listening directly to the people who have lived through the experience. They conducted a study involving seven adults who had previously received care from a public psycho-oncology service. These participants, mostly women with breast or gynaecological cancers, took part in two video conference discussions. The researchers did not just ask if the idea sounded good; they explored the deep, practical feelings people had about sharing a room with strangers who might be fighting a different kind of cancer or facing a different future. The goal was to understand if a mixed group could provide the comfort of shared humanity without triggering the fear of the unknown.
The participants found that mixing people with different types of cancer was largely acceptable, provided the conversation focused on shared emotional challenges rather than medical details. When the group discussed feelings like fear, loneliness, or the struggle to find meaning, the specific name of the tumor mattered less than the common experience of being a person with cancer. One participant noted that the group felt like a place where everyone was simply human, regardless of their specific diagnosis. This shared understanding helped reduce the isolation that often follows a diagnosis, allowing people to feel validated by peers who truly understood the weight of their situation. The group setting was seen as a powerful way to learn from others, offering practical tips on how to manage treatment side effects or navigate the healthcare system, which in turn built confidence.
However, the question of mixing different stages of illness—combining those who have just been diagnosed with those who are nearing the end of their lives—elicited a more complex response. While some participants saw value in hearing from those further along in their journey, finding inspiration and hope in their resilience, others felt a sharp spike in anxiety. There was a genuine concern that hearing about a fellow group member's cancer returning or passing away could send a person's mind into a spiral of worst-case scenarios. One participant described how seeing someone else's treatment fail and hearing of their death shortly after caused their own mind to race with fear about their own future. This suggests that while the idea of a mixed-stage group is not impossible, it requires careful handling to ensure that the emotional safety of the most vulnerable members is not compromised.
The study also highlighted that group therapy should never be viewed as a replacement for one-on-one sessions. Participants were clear that while the group offered unique benefits like peer connection and normalization of feelings, it could not replace the privacy needed to discuss deeply personal or sensitive issues. They worried that in a group, they might hold back important details for fear of being judged or having their private stories shared outside the room. Additionally, practical barriers like travel time, work schedules, and the emotional energy required to attend a session were significant hurdles. The researchers noted that the group dynamics themselves could be tricky; if one person dominated the conversation or shared too much too soon, it could make others uncomfortable.
Ultimately, the findings suggest that mixed-tumor groups are a viable and acceptable option for cancer care, but they must be structured with care. The content should focus on the universal psychological challenges of living with cancer rather than disease-specific facts. To make mixed-stage groups work, facilitators would need to be skilled at managing the emotional temperature of the room, perhaps by acknowledging the different stages of the journey while emphasizing the common ground that binds the group together. The researchers concluded that these groups could significantly improve access to mental health support in a system where resources are stretched thin, but they must be offered alongside, not instead of, individual therapy. By carefully balancing the need for connection with the need for psychological safety, healthcare providers can create spaces where people with cancer feel less alone, without exposing them to unnecessary distress.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.